Oxidative Stress Up-regulates Presenilin 1 in Lipid Rafts in Neuronal Cells
Overview
Authors
Affiliations
Oxidative stress is associated with beta-amyloid peptide (A beta) accumulation in the brains of Alzheimer's disease patients. A beta is generated upon the sequential proteolytic cleavage of transmembrane amyloid precursor protein (APP) by two membrane-bound proteases, beta-secretase (BACE1) and the gamma-secretase complex comprising presenilin 1 (PS1), nicastrin, APH-1 and PEN-2. Recent evidence suggests that significant amounts of BACE1 and gamma-secretase components localize in the cholesterol-rich region of membranes known as lipid rafts, where A beta production occurs preferentially. In this study, we investigated the effects of oxidative stress on the BACE1 and gamma-secretase components in lipid rafts using human neuroblastoma SH-SY5Y cells exposed to ethacrynic acid (EA), a compound that induces cellular glutathione depletion. Following exposure of cells to EA, heme oxygenase-1, a marker protein of oxidative stress, was strongly induced. Moreover, treatment with EA resulted in a significant increase in PS1 protein levels, but not those of nicastrin, APH-1, PEN-2 or BACE1, in both cell lysates and the lipid raft fraction. This increase in PS1 protein expression was prevented by co-treatment with an antioxidant, N-acetylcysteine (NAC). EA additionally induced a significant increase in PS1 mRNA expression, which was inhibited by NAC. Finally, EA treatment was found to promote A beta secretion from cells expressing Swedish mutant APP. It appears that in our cell culture model, oxidative stress enhances PS1 protein levels in lipid rafts via up-regulation of PS1 transcription, which may constitute the mechanism underlying the oxidative stress-associated promotion of A beta production.
Sun Y, Islam S, Michikawa M, Zou K Int J Mol Sci. 2024; 25(3).
PMID: 38339035 PMC: 10855926. DOI: 10.3390/ijms25031757.
The oDGal Mouse: A Novel, Physiologically Relevant Rodent Model of Sporadic Alzheimer's Disease.
Chadwick W, Maudsley S, Hull W, Havolli E, Boshoff E, Hill M Int J Mol Sci. 2023; 24(8).
PMID: 37108119 PMC: 10138655. DOI: 10.3390/ijms24086953.
Tang X, Zhao Y, Liu Y, Liu Y, Liu Y, Niu F J Cell Mol Med. 2022; 26(4):1024-1033.
PMID: 35044105 PMC: 8831957. DOI: 10.1111/jcmm.17153.
Toshikawa H, Ikenaka A, Li L, Nishinaka-Arai Y, Niwa A, Ashida A Sci Rep. 2021; 11(1):17377.
PMID: 34462463 PMC: 8405674. DOI: 10.1038/s41598-021-96697-7.
Diabetes and Alzheimer's Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path?.
Potenza M, Sgarra L, Desantis V, Nacci C, Montagnani M Antioxidants (Basel). 2021; 10(8).
PMID: 34439505 PMC: 8389322. DOI: 10.3390/antiox10081257.